Patents by Inventor Maria Arranz

Maria Arranz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Predicting a response to risperidone
    Publication number: 20110287417
    Abstract: The invention relates generally to the relative effect of specific genetic polymorphisms in predicting the clinical outcome of risperidone therapy in patients suffering from a psychiatric disease such as schizophrenia.
    Type: Application
    Filed: April 9, 2010
    Publication date: November 24, 2011
    Inventor: Maria Arranz
  • Predicting a response to olanzapine
    Publication number: 20110223593
    Abstract: The invention relates generally to the relative effect of specific genetic polymorphisms in predicting the clinical outcome of olanzapine therapy in patients suffering from a psychiatric disease such as schizophrenia.
    Type: Application
    Filed: April 9, 2010
    Publication date: September 15, 2011
    Applicant: Optimal Medicine Ltd.
    Inventor: Maria Arranz
  • Predicting a response to risperidone
    Publication number: 20090042194
    Abstract: The invention relates generally to the relative effect of specific genetic polymorphisms in predicting the clinical outcome of risperidone therapy in patients suffering from a psychiatric disease such as schizophrenia.
    Type: Application
    Filed: December 18, 2007
    Publication date: February 12, 2009
    Inventor: Maria Arranz
  • Predicting a response to olanzapine
    Publication number: 20080206768
    Abstract: The invention relates generally to the relative effect of specific genetic polymorphisms in predicting the clinical outcome of olanzapine therapy in patients suffering from a psychiatric disease such as schizophrenia.
    Type: Application
    Filed: December 18, 2007
    Publication date: August 28, 2008
    Inventor: Maria Arranz